english.prescrire.org > Spotlight > 100 most recent > GLP-1 agonists: thyroid cancer (continued)

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

GLP-1 agonists: thyroid cancer (continued)

 Adverse Effects  According to a meta-analysis of 44 randomised clinical trials including a total of 84 000 patients, exposure to a GLP-1 agonist is associated with an approximately 1.6-fold risk of thyroid cancer compared to non-exposure.
Full article available for download by subscribers

 ©Prescrire 1 July 2026

Source: "GLP-1 agonists: thyroid cancer (continued)" Prescrire Int 2026; 35 (283): 185. Subscribers only.

Filet

Enjoy full access to Prescrire International, and support independent information